MAPS Public Benefit Corp

MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements
Fierce Biotech
Fri, 09/15/23 - 11:43 am
MDMA
MAPS Public Benefit Corp
clinical trials
PTSD
psychedelic drugs